THE WELCH COMPANY
440 Davis Court #1602
San Francisco, CA 94111-2496
415 781 5700
rodwelch@pacbell.net
S U M M A R Y
DIARY: January 27, 2009 01:44 PM Tuesday;
Rod Welch
Millie letter medical team agenda meeting UCSF 090129 start new treatment.
1...Summary/Objective
..............
Click here to comment!
CONTACTS
SUBJECTS
Default Null Subject Account for Blank Record
0403 -
0403 - ..
0404 - Summary/Objective
0405 -
040501 - Follow up ref SDS 28 0000. ref SDS 27 0000.
040502 -
040503 -
040504 -
040505 -
040506 -
040508 - ..
0406 -
0407 -
0408 - Progress
0409 -
040901 - Background...
040902 -
040903 - 1. Case study dilemma balancing sunitinib treatments to optimize
040904 - recovery from 5th relapse IBC, and without increasing
040905 - debilitating side effects that prevent exercise required to
040906 - benefit from recovery. ref SDS 9 I87N
040908 - ..
040909 - 2. On 090108 examination at UCSF showed possible progression of
040910 - IBC in breastbone area, as set out in Millie's letter to the
040911 - medical team on 090109. ref SDS 11 UC4H Millie reported severe
040912 - side effects shown by wide range of blood counts falling.
040913 - ref SDS 11 UF3Q Medical team prescribed another cycle
040914 - sunitinib treatment, with cyclophosphamide paused until blood
040915 - counts increase to a safe level. ref SDS 11 UF3T
040917 - ..
040918 - 3. On 090109 Millie's letter reports rise of IBC with sunitinib
040919 - seen at UCSF on 090108 occurred previously, cited in Millie's
040920 - letter on 081125, ref SDS 4 XX4P; there was rise of IBC and
040921 - then substantial recovery reported again on 081217, ref SDS 5
040922 - YJ4V; on 081230 Millie's letter reported on 081224 and 081225
040923 - rise of IBC, and then improvement on 081226, ref SDS 9 JV5M;
040924 - most recently on 090106 Millie cited again advance of IBC on
040925 - 081224 and 081225, and now disease seems to be subsiding again.
040926 - ref SDS 10 YO4V]
040928 - ..
040929 - 4. On 090115 Millie letter to Catherine and Diane in the Infusion
040930 - Clinic at UCSF reported rising side effects of sunitinib
040931 - protocol, ref SDS 14 5J9Y; she tried hiking a few times, but
040932 - this hurts her feet (peripheral neuropathy) and legs are very
040933 - weak, shown in patient history on daily treatments. ref SDS 13
040934 - KL4J Have been spending more time in the gym doing aerobics,
040935 - which is a little more tolerable. ref SDS 13 3E4K
040937 - ..
040938 - 5. On 090116 Glenna called to ask about response to treatment and
040939 - side effects, ref SDS 15 JY6L, and was advised that IBC in the
040940 - breastbone area was stable to worse, and other sites are stable
040941 - to improved with sunitinib protocol, citing the record of
040942 - patient history the day before on 090115. ref SDS 13 124N
040944 - ..
040945 - 6. On 090116 during call from Glenna advised that Millie wants to
040946 - reduce the dose of sunitinib in order to reduce debilitating
040947 - side effects, and requested remedy to reduce side effects with
040948 - full dose of sunitinib in order to optimize recovery.
040949 - ref SDS 15 JY7J
040951 - ..
040952 - 7. On 090116 Millie received a letter from Glenna transmitting a
040953 - copy of a letter Glenna wrote to the doctor reporting
040954 - understandings from telecon in the morning on 090116,
040955 - ref SDS 17 YN9H; Glenna's letter to the doctor described
040956 - difficulty tolerating side effects of sunitinib, ref SDS 17
040957 - 4P5M, that Millie wants to reduce the dose to reduce side
040958 - effects, but is afraid about losing benefits of recovering
040959 - from IBC. ref SDS 17 HV3M
040961 - ..
040962 - 8. On 090116 Glenna's letter to the doctor asked about changing to
040963 - another treatment. ref SDS 17 HV3O
040965 - ..
040966 - 9. On 090116 Glenna planned to meet with the doctor later in the
040967 - day on 090116 to discuss changing Millie's treatment.
040968 - ref SDS 17 HP4J
040970 - ..
040971 - 10. On 090116 Millie's letter to the medical team clarifies telecon
040972 - on condition following examination at UCSF on 090108, reporting
040973 - IBC in breastbone area looks stable to worse, and everywhere
040974 - else looks improved to stable, indicating recovery has slowed
040975 - ref SDS 18 IS6G, relative to findings on 081218, ref SDS 6
040976 - VD4F, confirmed in Millie's letter later that day reporting
040977 - significant recovery. ref SDS 7 GF8V
040979 - ..
040980 - 11. On 090118 Millie talks about wanting to end treatment with
040981 - sunitinib that seems now less effective and has severe side
040982 - effects after adding cycloposphamide. ref SDS 19 UC41
040984 - ..
040985 - 12. On 090121 Millie letter to primary care physician says very
040986 - pleased to take this occasion on my birthday to say thanks for
040987 - such great care the past 7 years. You noted in our first
040988 - meeting on 020321 that Oncology presents unique challenges.
040989 - ref SDS 1 R94H My case has been complicated by other maladies
040990 - that strain resources of time, money, and emotion. Having you
040991 - at the helm with Arlette's assistance has been a blessing.
040992 - ref SDS 22 F23Y
040994 - ..
040995 - 13. On 090121 Glenna calls and asks again about Millie's response
040996 - to treatment, ref SDS 23 AJ3J, following up her call on 090116,
040997 - ref SDS 15 JY6L, and per background above. ref SDS 23 JY5I
040999 - ..
041000 - 14. On 090121 during call from Glenna reported patient history,
041001 - ref SDS 23 ZO4F, on 090120 shows IBC rash looks improved to
041002 - stable, and nodules in the breastbone area seem worse,
041003 - ref SDS 21 124N, relative to detailed review on 090110,
041004 - ref SDS 12 124N, and after 11 days of treatment with only
041005 - sunitinib, and 25 total treatments with sunitinib, since the
041006 - pause on 081218 and resuming on 081226. ref SDS 20 6C4J
041008 - ..
041009 - 15. On 090121 during call from Glenna reported patient history
041010 - reported IBC worsening in breastbone area has progressed onto
041011 - the right breast and spread toward the left chest reflects
041012 - rising cancer marker, ref SDS 23 N95K, Labs at Kaiser on 090116
041013 - report CA 15-3 303. ref SDS 16 PQTQ This record indicates
041014 - Millie has suffered 6th relapse of IBC.
041016 - ..
041017 - 16. On 090121 Glenna asked for most severe side effects from
041018 - continuing with sunitinib treatment. ref SDS 23 TW53
041020 - ..
041021 - 17. On 090121 Glenna asked for Millie's records on Doctor Rugo's
041022 - plans for follow on treatments? During the call developed
041023 - background on UCSF planning for Millie's future treatment after
041024 - sunitinib. ref SDS 23 Y67L
041026 - ..
041027 - 18. On 090121 Glenna reported during the call that she would send
041028 - another letter to Doctor Rugo explaining Millie's slow response
041029 - to treatment with sunitinib, and supplementing Glenna's letter
041030 - to the doctor on 090116, ref SDS 0 SY5J; Glenna further advised
041031 - during the call on 090121 that she would meet again with Doctor
041032 - Rugo to discuss plans for changing Millie's treatment to
041033 - recover from Millie's 6th IBC relapse. ref SDS 23 N976
041035 - ..
041036 - 19. On 090121 patient history summarized to faciliate Glenna's
041037 - meeting with Doctor to figure out Millie's next treatment.
041038 - ref SDS 23 NU5H
041040 - ..
041041 - a. Laboratory blood tests listed for Millie to facilitate UCSF
041042 - considering Millie's next treatment. ref SDS 23 6Y9K
041044 - ..
041045 - b. Image test history of PET, CT, Xray, MRI listed for Glenna
041046 - to discuss with Doctor Rugo discussing Millie's next
041047 - treatment. ref SDS 23 216F
041049 - ..
041050 - c. Treatment history listed for Glenna to discuss with Doctor
041051 - Rugo discussing Millie's next treatment. ref SDS 23 H16M
041053 - ..
041054 - d. Strategy considerations for selecting Millie's next
041055 - treatment. ref SDS 23 558O
041057 - ..
041058 - 20. On 090122 telephone message from Glenna reported that the
041059 - doctor ended treament with sunitinib protocol; Glenna met with
041060 - Doctor Rugo to develop treatment plan for Millie, and UCSF
041061 - scheduled Millie to start new treatment on 090129. ref SDS 27
041062 - K96F
041064 - ..
041065 - 21. On 090123 primary care physician at Kaiser cited sudden relapse
041066 - of IBC with nodules spreading in the breastbone area, and
041067 - cancer marker elevated to CA 15-3 303 in the labs at Kaiser on
041068 - 090116, ref SDS 16 PQTQ, shows Millie needs immediate change of
041069 - treatment to prevent cancer from cascading out of control, and
041070 - that UCSF should prescribe treatment, ref SDS 32 RK6O, because
041071 - Millie's 6th relapse of IBC shows cancer has mutated to cells
041072 - that are now very resistant to treatments available at Kaiser,
041073 - as discussed previously during the meeting at Kaiser on 080829,
041074 - and cited in Millie's letter to the medical team. ref SDS 3
041075 - RP9R
041077 - ..
041078 - 22. On 090123 Millie's letter to medical team reports progress at
041079 - UCSF scheduling Millie to start on a new treatment. ref SDS 28
041080 - KR4P
041082 - ..
041083 - 23. On 090123 Glenna called and thanked her for expediting Millie's
041084 - new treatment to start on 090129 so that cancer does not
041085 - cascade out of control, ref SDS 29 TR80; request documentation
041086 - on new treatment in order to be prepared starting on 090129
041087 - 0830, as presented in Glenna's telephone message on 090122,
041088 - ref SDS 27 AT6N
041090 - ..
041091 - 24. On 090123 Glenna advised during her call that there was not
041092 - enough time to meet with Doctor Rugo on 090121; she received a
041093 - letter from the doctor to coordinate with Kaiser on getting
041094 - timely referral to start Millie's next treatment at UCSF on
041095 - 090129. ref SDS 29 118M
041097 - ..
041098 - 25. On 090123 Doctor Johnson, Millie's primary care physician at
041099 - Kaiser, called and confirmed prior advice that Doctor Rugo can
041100 - prescribe follow on treatment for Millie because her cancer has
041101 - become resistant to drugs available at Kaiser. ref SDS 32 8K6K
041103 - ..
041104 - This afternoon, Millie submitted a letter to the medical team with an
041105 - agenda for meeting at UCSF on 090129, and saying...
041106 -
041107 - 1. Subject: Meeting Jan 29 UCSF Prescribe New Treatment
041108 - Date: Tue, 27 Jan 2009 13:52:29 -0800
041121 - ..
041122 - 2. Here is the blood test report for labs at Kaiser on 090122
041123 - during treatment in the ER. ref SDS 25 S65I
041125 - ..
041126 - Note WBC 8.6, platelets 153, INR 3.7.
041128 - ..
041129 - 3. Doctor Johnson called the next day to implement planning in the
041130 - ER for follow up on 090123. ref SDS 32 ZI5I Doctor Johnson
041131 - expressed confidence in Doctor Rugo prescribing immediate
041132 - treatment for the 6th relapse of IBC, ref SDS 32 8K6K, noted in
041133 - your phone message on 090122, ref SDS 27 J47F [and which would
041134 - start at UCSF on 090129 to prevent losing control, after
041135 - toxicity from the prior treatment dissipates. ref SDS 27 AT6N]
041136 -
041137 - [On 090130 Millie's letter to medical team reports
041138 - Doctor Rugo prescribed on 090129 hypertheria with Docil
041139 - treatment for local control of Millie's 6th IBC relapse,
041140 - and will be provided in the UCSF Radiation Oncology
041141 - Department. ref SDS 35 AY9Q
041143 - ..
041144 - [On 090130 letter to medical team reports communication
041145 - delay cited during meeting the day before at UCSF on
041146 - 090129 Doctor Rugo explained Glenna was coordinating a
041147 - week earlier, i.e., on 090122, with Kaiser for referral
041148 - to provide hyperthermia treatment to Millie in time to
041149 - be effective. ref SDS 35 AY8Q
041151 - ..
041152 - 4. INR 3.7 is elevated; Gloria in the Coagulation Control Clinic
041153 - continued current dose until the lab at UCSF on Thursday,
041154 - 090129, and in order to assess effect of ending sunitinib and
041155 - cyclophosphamide.
041157 - ..
041158 - 5. In your call on 090121, you asked about UCSF planning for
041159 - follow up treatments. Here is reminder of those
041160 - understandings. ref SDS 23 Y67L
041162 - ..
041163 - 6. Additionally, my full treatment history is listed to facilitate
041164 - planning on Thursday. ref SDS 23 H16M
041166 - ..
041167 - 7. I asked in the letter on 090123 about elevated eosinophils 700%
041168 - high in the lab at Kaiser on 090119 [actually 090116].
041169 - ref SDS 16 FV5M
041171 - ..
041172 - 8. Since this is new in patient history, I wanted feedback on
041173 - correlations and implications. Hopefully, we can discuss on
041174 - Thursday.
041176 - ..
041177 - 9. I'm not feeling my best. I was able to drive the car and do
041178 - some small errands yesterday, so that was positive. Pain in
041179 - the shoulder is mostly gone; thank God, because I hate 1-armed
041180 - push ups (just joking).
041182 - ..
041183 - 10. Side effects of feeling "lousy" from chemo have subsided. My
041184 - feet are better and energy is rising, so maybe I can start
041185 - hiking. [as a result of ending sunitinib treatments ordered by
041186 - Doctor Rugo in Glenna's phone message on 090122, ref SDS 27
041187 - K96F, and cited in Millie's letter to the medical team on
041188 - 090123. ref SDS 28 KR4P
041190 - ..
041191 - 11. Reminder to Catherine and Diane I need labs on Thursday at 0800
041192 - with INR, CA 15-3, etc. Hopefully, there will be full scope to
041193 - start a new treatment, since cancer seems to be advancing.
041194 -
041201 -
041202 -
041203 -
041204 -
041205 -
041206 -
041207 -
041208 -
041209 -
041210 -
0413 -